HTFL (HeartFlow) Notes Receivable: $0.0 Mil (As of Mar. 2026)


HTFL HeartFlow Inc HTFL
12 GF Score
Price $29.33
! 4 Warning Signs
View Full Analysis

What is HeartFlow Notes Receivable?

HeartFlow HTFL -15.83% 12 Notes Receivable is $0.0 Mil as of Mar. 2026. GuruFocus rates HTFL with a GF Score™ of 12/100. The stock has 4 warning signs investors should review.

HeartFlow's Notes Receivable for the quarter that ended in Mar. 2026 was $0.0 Mil.

HeartFlow Notes Receivable Historical Data

* Premium members only.

The historical data trend for HeartFlow's Notes Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

HeartFlow Notes Receivable Chart

HeartFlow Annual Data
Trend Dec23 Dec24 Dec25
Notes Receivable
0.00 0.00 0.00

HeartFlow Quarterly Data
Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Notes Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
HTFL
12GF Score
HeartFlow Inc HTFL
Notes Receivable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

HeartFlow Notes Receivable Calculation

Notes Receivable is an unconditional promise to receive a definite sum of money at a future date(s) within one year of the balance sheet date or the normal operating cycle, whichever is longer.

Frequently Asked Questions Learn more about Notes Receivable →
What does a Notes Receivable of $0.0 Mil mean?
HeartFlow (HTFL) has a Notes Receivable of $0.0 Mil as of Mar. 2026. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on HeartFlow and its competitors.
Is HeartFlow's Notes Receivable too high?
HeartFlow's current Notes Receivable is $0.0 Mil. Overall, HeartFlow has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does HeartFlow's Notes Receivable compare to PRVA and WAY?
HeartFlow's Notes Receivable of $0.0 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Notes Receivable for a Healthcare Providers & Services company?
A good Notes Receivable depends on the Healthcare Providers & Services industry context. However, Notes Receivable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Notes Receivable mean?
A high Notes Receivable can signal that a stock is expensive relative to its fundamentals. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on HeartFlow and its competitors. HeartFlow's current Notes Receivable is $0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is HeartFlow stock overvalued right now?
HeartFlow (HTFL) has a current Notes Receivable of $0.0 Mil. The current Notes Receivable is $0.0 Mil. HeartFlow's overall GF Score™ is 12/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Notes Receivable calculated?
Notes Receivable is calculated from a company's financial statements. For HeartFlow (HTFL), the current Notes Receivable is $0.0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

HeartFlow Business Description

Address 331 East Evelyn Avenue, Mountain View, CA, USA, 94041
HeartFlow Inc is a commercial-stage medical technology company that provides software and artificial intelligence (AI) designed to deliver a non-invasive solution for diagnosing and managing coronary artery disease. The company operates and manages its business as a single reportable operating segment: non-invasive coronary artery disease detection solutions. Geographically, it operates in the United States and the rest of Europe, deriving the majority of its revenue from the United States. The company has developed three software products: Heartflow Roadmap Analysis, Heartflow FFRCT Analysis, and Heartflow Plaque Analysis.
12GF Score

Get the complete analysis for HTFL

Notes Receivable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$29.33
Price